Hi, help us enhance your experience
Hi, help us enhance your experience
Hi, help us enhance your experience
825 Views
eMediNexus 25 January 2018
The National Institutes of Health (NIH) has launched a large international study - IMPAACT 2010 or VESTED (Virologic Efficacy and Safety of Antiretroviral Therapy Combinations with TAF/TDF, EFV and DTG) – to evaluate the current preferred first-line regimen (efavirenz (EFV), lamivudine (3TC) or emtricitabine (FTC), and tenofovir disoproxil fumarate (TDF) for pregnant women recommended by the World Health Organization (WHO) and two regimens containing a newer drug, dolutegravir (DTG), and either tenofovir alafenamide (TAF)… (NIH, January 24, 2018)
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}..
Detecting Intra-abdominal Adhesions in Women with Repeated C-sections..
Maintaining Liver Health to Optimize Glycemic Outcomes in Early Type 2.....
Antibiotic Prescribing Practices for Pediatric Acute Otitis Media..
Hidden Hazard of Indoor Pollution in COPD..
Recognizing Pitfalls of Point-of-Care Lung Ultrasound..
{{Article_Title}}..
Bombay HC Questions Denial of Motherhood to Woman with Intellectual Disability..
HMPV Outbreak in India: Health Minister Warns of Similar Symptoms to COVID-19, States Prepare Special ICU Wards..
Maharashtra Medical Education Minister Warns Children and Elderly to Stay Alert amid HMPV Cases..
Medical Negligence in Rewa: Surgical Needle Left inside Woman's Abdomen for Two Years..
HMPV in India: Seven Cases Reported across Four States..